10.07.2014 16:01:33

Press Release: Nestle: Nestlé acquires rights to aesthetic dermatology products in the US and Canada

-1 of 2- 10 Jul 2014 13:30:00 UTC  *DJ Nestle: Nestlé acquires rights to aesthetic dermatology products in the US and Canada

   (MORE TO FOLLOW) Dow Jones Newswires

   July 10, 2014 09:30 ET (13:30 GMT)- - 09 30 AM EDT 07-10-14

-2 of 2- 10 Jul 2014 13:30:00 UTC  Press Release: Nestle: Nestlé acquires rights to aesthetic dermatology products in the US and Canada

Nestlé S.A. / Nestlé acquires rights to aesthetic dermatology products in the US and Canada . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Read the press release online http://www.nestle.com/Media/PressReleases/AllPressReleases/nestle-acquires-aesthetic-dermatology-products , also available in French (pdf): http://www.nestle.com/asset-library/Documents/Media/press-release/2014-july/Nestle-acquisition-valeant-complete-FR.pdf and German (pdf): http://www.nestle.com/asset-library/Documents/Media/press-release/2014-july/Nestle-acquisition-valeant-complete-DE.pdf

..................................

Vevey, 10 July 2014 - As a result of the successful conclusion of the regulatory process and customary closing conditions, Nestlé today completed its acquisition of Valeant Pharmaceuticals International's commercialisation rights to several key injectable aesthetic dermatology products in the US and Canada, as announced on 28 May 2014. These rights will be integrated into Nestlé Skin Health and commercialised by Galderma.

Based in Lausanne, Nestlé Skin Health is a global leader focused on enhancing the quality of life by delivering science-based solutions for the health of skin, hair and nails. Galderma, with approximately 5,000 employees and a presence in 80 countries, is the pharmaceutical arm of Nestlé Skin Health.

Contacts

Media: Robin Tickle Tel.: +41 21 924 22 00

Investors: Tel.: +41 21 924 35 09

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Nestlé S.A. via Globenewswire

HUG#1821012

--- End of Message ---

Nestlé S.A.

Avenue Nestlé 55 Vevey Switzerland

WKN: 887208;ISIN: CH0038863350;

http://www.nestle.com (END) Dow Jones Newswires

   July 10, 2014 09:30 ET (13:30 GMT)- - 09 30 AM EDT 07-10-14

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Nestle S.A. (spons. ADRs)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Nestle S.A. (spons. ADRs) 79,40 -1,00% Nestle S.A. (spons. ADRs)

Indizes in diesem Artikel

NASDAQ Comp. 20 109,06 -0,32%